公司資料
Virax Biolabs 股價、新聞與催化劑
- 股票代碼:
- VRAX
- 交易所:
- NASDAQ
- 產業:
- MedTech
- 所在地:
- United Kingdom and listed in the U
股票表現
2.24 USD (+2.56%)
收盤價
最後更新: 2026年10月1日
1.61M USD
市值
股價為何變動
截至 2026年10月1日，VRAX 上漲 2.56%，收於 $2.24。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
業務概覽
Virax Biolabs is a diagnostics company focused on immune profiling and infectious-disease testing. Its business is centered on molecular and laboratory diagnostics rather than therapeutics.
所在地與產業分類
Virax Biolabs is headquartered in the United Kingdom and listed in the U.S. market. It sits in diagnostics and medical devices rather than biotechnology.
商業模式特徵
The company depends on product adoption, test utilization, and commercialization in a competitive diagnostics market. Investors watch market access, product rollout, and operating execution.
生技產業定位
Virax occupies the diagnostics layer of the healthcare stack. It is not a biotech drug name, but it belongs to the broader testing infrastructure that supports care decisions.
未來催化劑
- Virax’s catalysts are infectious-disease and immune-profiling programs, plus any update that shows the platform can still create value. The next step matters because the company remains early.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。